US Broker Ratings

Humana Inc. (HUM) Stock Analysis: Navigating a 30% Potential Upside Amidst Healthcare Sector Dynamics

Humana Inc. (NYSE: HUM), a heavyweight in the healthcare plans industry, stands as a compelling consideration for investors eyeing growth within the healthcare sector. With a substantial market capitalization of..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 73% Potential Upside Amidst Challenging Metrics

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative mRNA-based therapeutic solutions. Despite facing a turbulent period in its..

West Pharmaceutical Services (WST) Stock Analysis: Healthcare Giant with 25% Upside Potential

West Pharmaceutical Services, Inc. (WST), a key player in the healthcare sector, is capturing the attention of investors with a compelling growth potential. With a market capitalization of $16.14 billion,..

Centene Corporation (CNC) Stock Analysis: Unlocking a Potential 39% Upside Amidst Market Challenges

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, stands out with a market capitalization of $27.45 billion. Operating primarily in the healthcare plans industry, Centene delivers a..

Boston Scientific Corporation (BSX) Stock Analysis: A 14.63% Upside Potential Amid Robust Revenue Growth

Boston Scientific Corporation (NYSE: BSX), a leading player in the medical devices sector, offers a compelling investment proposition with a notable 14.63% potential upside, as indicated by the average analyst..

Grifols, S.A. (GRFS) Stock Analysis: Unlocking a 22.85% Potential Upside with Its Global Plasma Leadership

Grifols, S.A. (GRFS), a leading player in the healthcare sector, particularly within the general drug manufacturing industry, is drawing attention from investors with its significant potential upside of 22.85%. Based..

Elanco Animal Health (ELAN) Stock Analysis: Navigating the Path with Strong Free Cash Flow and Growth Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, offers a diverse portfolio of products for the..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring Growth Potential with a 4.24% Upside

Cardinal Health, Inc. (CAH), a prominent player in the healthcare sector, operates within the medical distribution industry, delivering essential services and products across the globe. With its headquarters in Dublin,..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Analyzing the 83.45% Potential Upside in Biotech

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a noteworthy contender in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $15.29 billion, this Miami-based biopharmaceutical company..

Verona Pharma (VRNA) Stock Analysis: Exploring a Significant 12% Upside Potential in the Biotech Sector

Verona Pharma plc (NASDAQ: VRNA), a key player in the biotechnology industry, has captured investor attention with its promising prospects in the healthcare sector. Operating out of London, this biopharmaceutical..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 30% Potential Upside Amidst Challenging Market Conditions

Illumina, Inc. (NASDAQ: ILMN), a leading player in the diagnostics and research sector, stands at a crucial juncture as investors weigh its growth potential against current market challenges. With a..

Globus Medical, Inc. (GMED): Investor Outlook Reveals 42% Upside Potential in the Healthcare Sector

For investors navigating the healthcare sector, Globus Medical, Inc. (NYSE: GMED) presents a compelling opportunity, particularly given its substantial upside potential of 42.13%. As a leading player in the medical..

Quest Diagnostics (DGX) Stock Analysis: Navigating a 5.5% Upside with Strong Revenue Growth

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, continues to capture investor attention. As a leader in the Diagnostics & Research industry, Quest Diagnostics is strategically..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth and Innovation in Healthcare Technology

Masimo Corporation (NASDAQ: MASI), a key player in the healthcare sector specializing in medical devices, has demonstrated impressive strides in innovation and market presence. With a current market capitalization of..

Corcept Therapeutics (CORT) Stock Analysis: Unlocking Potential with Nearly 99% Upside

Investors looking for opportunities in the biotechnology sector should cast their eyes on Corcept Therapeutics Incorporated (CORT). With a market capitalization of $7.38 billion, Corcept operates within the healthcare sector,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unpacking a 69% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a distinguished player in the biotechnology sector, with its focus on developing life-saving therapies for rare diseases. With a market capitalization of $10.86 billion,..

Waters Corporation (WAT) Stock Analysis: Understanding the 10% Upside in the Healthcare Sector

Waters Corporation (NYSE: WAT) stands as a global leader in the diagnostics and research industry, a pivotal segment of the healthcare sector. With its headquarters in Milford, Massachusetts, and a..

Repligen Corporation (RGEN) Stock Analysis: A Strong Buy with 42.83% Upside Potential

Repligen Corporation (NASDAQ: RGEN) has captured the attention of investors with an impressive potential upside of 42.83% based on current analyst ratings. Operating within the thriving healthcare sector, specifically the..

Ascendis Pharma A/S (ASND) Stock Analysis: A 30% Potential Upside with Solid Buy Ratings

Ascendis Pharma A/S (NASDAQ: ASND), a prominent name in the biotechnology sector, is carving out a robust niche in the healthcare industry. Specializing in developing TransCon-based therapies to address unmet..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 35% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents an intriguing proposition with its diversified portfolio in medical devices and health technology. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds